Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Microbix Biosystems Inc (MBXBF)

Microbix Biosystems Inc (MBXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.62
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1653 +3.75%
on 03/25/26
0.1900 -9.74%
on 03/11/26
-0.0063 (-3.54%)
since 02/25/26
3-Month
0.1553 +10.43%
on 01/21/26
0.1900 -9.74%
on 03/11/26
+0.0074 (+4.51%)
since 12/22/25
52-Week
0.1537 +11.58%
on 12/18/25
0.3050 -43.77%
on 03/28/25
-0.1135 (-39.82%)
since 03/26/25

Most Recent Stories

More News
Microbix Announces Annual Meeting Voting Results

MISSISSAUGA, ON / ACCESS Newswire / March 26, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQB:MBXBF) ("Microbix®" or the Company"), a life sciences innovator, manufacturer, and exporter, announces the...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Presents Reference-Material Innovations at EUROGIN

QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix's Clot-Buster Drug Project Advances

Drug Substance Manufacturing Methods Modernized

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Announces Issuance of Stock Options

Using Shareholder-Approved Plan to Incentivize and Retain

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Reports Results for Q1 2026

Q1 Revenues of $4.2 million and Controlled Net Loss

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs

MISSISSAUGA, ON / ACCESS Newswire / February 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the College...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Schedules Release of Results for Q1 Fiscal 2026

Results Release and Webinar Discussion on Morning of February 12, 2026

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Presents Molecular Pathology Platform Results

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Updates Investor Presentation on its Website

In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure)

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)

Key Turning Points

3rd Resistance Point 0.1795
2nd Resistance Point 0.1755
1st Resistance Point 0.1735
Last Price 0.1715
1st Support Level 0.1675
2nd Support Level 0.1635
3rd Support Level 0.1615

See More

52-Week High 0.3050
Fibonacci 61.8% 0.2472
Fibonacci 50% 0.2294
Fibonacci 38.2% 0.2115
Last Price 0.1715
52-Week Low 0.1537

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.